Rapid sample preparation and simultaneous quantitation of prostaglandins and lipoxygenase derived fatty acid metabolites by liquid chromatography-mass spectrometry from small sample volumes

被引:44
作者
Unterwurzacher, Ines [1 ,2 ]
Koal, Therese [1 ]
Bonn, Guenther K. [2 ]
Weinberger, Klaus M. [1 ]
Ramsay, Steven L. [1 ]
机构
[1] Biocrates Life Sci AG, A-6020 Innsbruck, Austria
[2] Leopold Franzens Univ Innsbruck, Inst Analyt Chem & Radiochem, Innsbruck, Austria
关键词
diabetes; fatty acid metabolites; liquid chromatography-mass spectrometry (LC-MS/MS); lipid oxidation products; prostaglandins;
D O I
10.1515/CCLM.2008.323
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Fatty acid metabolites play a key role in numerous physiological and pathological processes. A rapid liquid chromatography-mass spectrometry assay for the simultaneous determination of prostanoids, isoprostane and lipoxygenase (LOX) derived fatty acid metabolites in a small biological sample of only 20 mu L was developed. Methods: Human plasma samples were applied to a filter spot, extracted without prior derivatization and analyzed within 13 min. Detection of metabolites was performed on a triple quadrupole mass spectrometer in negative multiple-reaction monitoring detection mode. Application of this assay to various biological matrices was performed. Results: The validated assay was linear over the concentration range of 5-500 nmol/ L for prostanoids and isoprostane, 50-5000 nmol/ L for LOX-derived metabolites and 400-40,000 nmol/ L for fatty acids. Limits of quantitation were 0.4-233 nmol/ L, depending on the metabolite. Plasma samples from diabetic patients and controls showed significant increases in (+/-)9-HODE and 15(S)-HETE with p-values of 0.019 and 0.024, respectively. Conclusions: The small amount of 20 mL sample volume used in this assay and the demonstrated application to various sample types makes it an ideal routine analysis method for fatty acid metabolites. The resulting values for LOX-derived metabolites in diabetes mellitus type 2 samples support earlier findings about the role of lipid oxidation products in diabetes.
引用
收藏
页码:1589 / 1597
页数:9
相关论文
共 39 条
[1]  
[Anonymous], 2001, Guidance for industry, bioanalytical method validation
[2]   Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice [J].
Bleich, D ;
Chen, SY ;
Zipser, B ;
Sun, DX ;
Funk, CD ;
Nadler, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (10) :1431-1436
[3]   Determination of isoprostanes in urine samples from Alzheimer patients using porous graphitic carbon liquid chromatography-tandem mass spectrometry [J].
Bohnstedt, KC ;
Karlberg, B ;
Wahlund, LO ;
Jönhagen, ME ;
Basun, H ;
Schmidt, S .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 796 (01) :11-19
[4]  
Browne RW, 2000, CLIN CHEM, V46, P829
[5]  
Chace DH, 1998, CLIN CHEM, V44, P2405
[6]   Principles of analytical calibration/quantification for the separation sciences [J].
Cuadros-Rodriguez, Luis ;
Bagur-Gonzalez, M. Gracia ;
Sanchez-Vinas, Mercedes ;
Gonzalez-Casado, Antonio ;
Gomez-Saez, Antonio M. .
JOURNAL OF CHROMATOGRAPHY A, 2007, 1158 (1-2) :33-46
[7]   Detection and quantitation of eicosanoids via high performance liquid chromatography-electrospray ionization-mass spectrometry [J].
Deems, Raymond ;
Buczynski, Matthew W. ;
Bowers-Gentry, Rebecca ;
Harkewicz, Richard ;
Dennis, Edward A. .
LIPIDOMICS AND BIOACTIVE LIPIDS: MASS-SPECTROMETRY-BASED LIPID ANALYSIS, 2007, 432 :59-82
[8]   THE STABILITY OF 13,14-DIHYDRO-15 KETO-PGE2 [J].
FITZPATRICK, FA ;
AGUIRRE, R ;
PIKE, JE ;
LINCOLN, FH .
PROSTAGLANDINS, 1980, 19 (06) :917-931
[9]  
Guichardant M, 1997, CLIN CHEM, V43, P2403
[10]   Increased production of 12/15 lipoxygenase eicosanoids accelerates monocyte/endothelial interactions in diabetic db/db mice [J].
Hatley, ME ;
Srinivasan, S ;
Reilly, KB ;
Bolick, DT ;
Hedrick, CC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (28) :25369-25375